Literature DB >> 28446467

Para-bile-osis Establishes a Role for Nonbiliary Macrophage to Feces Reverse Cholesterol Transport.

J Mark Brown1, Ryan E Temel1, Gregory A Graf2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28446467      PMCID： PMC5546086          DOI： 10.1161/ATVBAHA.117.309224

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  6 in total

Review 1.  A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretion.

Authors:  Ryan E Temel; J Mark Brown
Journal:  Trends Pharmacol Sci       Date:  2015-04-27       Impact factor: 14.819

2.  Delineation of molecular changes in intrahepatic cholesterol metabolism resulting from diminished cholesterol absorption.

Authors:  Joyce J Repa; Stephen D Turley; Gang Quan; John M Dietschy
Journal:  J Lipid Res       Date:  2005-01-16       Impact factor: 5.922

3.  Transintestinal Cholesterol Transport Is Active in Mice and Humans and Controls Ezetimibe-Induced Fecal Neutral Sterol Excretion.

Authors:  Lily Jakulj; Theo H van Dijk; Jan Freark de Boer; Ruud S Kootte; Marleen Schonewille; Yared Paalvast; Theo Boer; Vincent W Bloks; Renze Boverhof; Max Nieuwdorp; Ulrich H W Beuers; Erik S G Stroes; Albert K Groen
Journal:  Cell Metab       Date:  2016-11-03       Impact factor: 27.287

4.  Blockade of cholesterol absorption by ezetimibe reveals a complex homeostatic network in enterocytes.

Authors:  Luke J Engelking; Matthew R McFarlane; Christina K Li; Guosheng Liang
Journal:  J Lipid Res       Date:  2012-04-22       Impact factor: 5.922

5.  Direct intestinal cholesterol secretion contributes significantly to total fecal neutral sterol excretion in mice.

Authors:  Astrid E van der Velde; Carlos L J Vrins; Karin van den Oever; Cindy Kunne; Ronald P J Oude Elferink; Folkert Kuipers; Albert K Groen
Journal:  Gastroenterology       Date:  2007-06-20       Impact factor: 22.682

6.  Transintestinal cholesterol excretion is an active metabolic process modulated by PCSK9 and statin involving ABCB1.

Authors:  Cédric Le May; Jean Mathieu Berger; Anne Lespine; Bruno Pillot; Xavier Prieur; Eric Letessier; M Mahmood Hussain; Xavier Collet; Bertrand Cariou; Philippe Costet
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-04-04       Impact factor: 8.311
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.